Prediagnostic telomere length and risk of B-cell lymphoma-results from the epic cohort study

International Journal of Cancer

Volumn 135, Issue 12, 2014, Pages 2910-2917

  Hosnijeh, Fatemeh Saberi ^a,b   Matullo, Giuseppe ^c,d   Russo, Alessia ^c   Guarrera, Simonetta ^c   Modica, Federica ^c,d   Nieters, Alexandra ^e   Overvad, Kim ^f   Guldberg, Per ^g   Tjønneland, Anne ^g   Canzian, Federico ^h   Boeing, Heiner ⁱ   Aleksandrova, Krasimira ⁱ   Trichopoulou, Antonia ^j,k   Lagiou, Pagona ^k,l,m   Trichopoulos, Dimitrios ^j,l,m   Tagliabue, Giovanna ⁿ   Tumino, Rosario ^o   Panico, Salvatore ^p   Palli, Domenico ^q   Olsen, Karina Standahl ^r   Weiderpass, Elisabete ^r,s,t,u   Dorronsoro, Miren ^v   Ardanaz, Eva ^w,x   Chirlaque, Maria Dolores ^x,y   Sánchez, María José ^x,z   Quirós, J Ramón ^aa   Venceslá, Adoración ^ab   Melin, Beatrice ^ac   Johansson, Ann Sofie ^ac   Nilsson, Peter ^ad   Borgquist, Signe ^ae   Peeters, Petra H ^af   Onland Moret, N Charlotte ^af   Bueno de Mesquita, H B ^af,ag,ah   Travis, Ruth C ^ai   Khaw, Kay Tee ^aj   Wareham, Nick ^aj,ak   Brennan, Paul ^al   Ferrari, Pietro ^al   Gunter, Marc J ^am   Vineis, Paolo ^c,ah   Vermeulen, Roel ^a,af   more..

^a UTRECHT UNIVERSITY   (Netherlands)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Human Genetics Foundation   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF FREIBURG   (Germany)

^f AARHUS UNIVERSITY   (Denmark)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^j HELLENIC HEALTH FOUNDATION   (Greece)

^k UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^m BIOMEDICAL RESEARCH FOUNDATION   (Greece)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o CIVILE M P AREZZO HOSPITAL   (Italy)

^p UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^q CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^r UNIVERSITY OF TROMSØ   (Norway)

^s CANCER REGISTRY OF NORWAY   (Norway)

^t KAROLINSKA INSTITUTE   (Sweden)

^u FOLKHÄLSAN RESEARCH CENTER   (Finland)

^v BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^w INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^x CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^y DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^z Andalusian School of Public Health   (Spain)

^aa Health Department of the Autonomous Government of Asturias   (Spain)

^ab CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ac UMEÅ UNIVERSITY   (Sweden)

^ad LUND UNIVERSITY   (Sweden)

^ae LUND UNIVERSITY HOSPITAL   (Sweden)

^af UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ag NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ah IMPERIAL COLLEGE LONDON   (United Kingdom)

^ai UNIVERSITY OF OXFORD   (United Kingdom)

^aj UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ak ADDENBROOKE S HOSPITAL   (United Kingdom)

^al INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^am IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Lymphoma; NHL; Prospective study; Telomeres

Indexed keywords

DNA;

ADULT; AGED; CASE CONTROL STUDY; CYTOLOGY; EUROPE; FEMALE; FOLLOW UP; GENETICS; HODGKIN DISEASE; HUMAN; INCIDENCE; LEUKOCYTE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK; RISK FACTOR; TELOMERE; ULTRASTRUCTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA; EUROPE; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; LEUKOCYTES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; TELOMERE;

EID: 84908666631     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28934     Document Type: Article

References (42)

1. Lundblad V, Szostak JW. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 1989;57:633-43.
2. Chan SRWL, Blackburn EH. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci 2004; 359:109-22.
3. Eisenberg DTA. An evolutionary review of human telomere biology: the thrifty telomere hypothesis and notes on potential adaptive paternal effects. Am J Human Biol 2011;23:149-67.
4. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008;88:557-79.
5. Bechter OE, Eisterer W, Pall G, et al. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res. 1998;58:4918-22.
6. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266: 2011-15.
7. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008;99: 1385-9.
8. Hosgood HD, III, Cawthon R, He X, et al. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer 2009;66:157-61.
9. Shen J, Terry MB, Gurvich I, et al. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007;67:5538-44.
10. Shen J, Gammon MD, Terry MB, et al. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 2009;124:1637-43.
11. De Vivo I, Prescott J, Wong JYY, et al. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev 2009;18:1152-6.
12. Broberg K, Björk J, Paulsson K, et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005;26:1263-71.
13. McGrath M, Wong JYY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol. Biomarkers Prev 2007;16:815-19.
14. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-8.
15. Shao L, Wood CG, Zhang D, et al. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 2007;178:1492-6.
16. Liu X, Bao G, Huo T, et al. Constitutive telomere length and gastric cancer risk: case control analysis in Chinese Han population. Cancer Sci 2009; 100:1300-5.
17. Hou L, Savage SA, Blaser MJ, et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol. Biomarkers Prev 2009;18:3103-9.
18. Risques RA, Vaughan TL, Li X, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev 2007;16:2649-55.
19. Xing J, Ajani JA, Chen M, et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res 2009;2:459-65.
20. Zee RYL, Castonguay AJ, Barton NS, et al. Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol. Biomarkers Prev 2009;18:2280-2.
21. Pooley KA, Sandhu MS, Tyrer J, et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 2010;70: 3170-6.
22. Widmann TA, Herrmann M, Taha N, et al. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol 2007;35:939-46.
23. Lan Q, Cawthon R, Shen M, et al. A Prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res 2009; 15:7429-33.
24. Wentzensen IM, Mirabello L, Pfeiffer RM, et al. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2011;20:1238-50.
25. Wu KD, Orme LM, Shaughnessy J, et al. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 2003;101: 4982-9.
26. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26:S6-14.
27. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
28. Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008.
29. Zee RYL, Michaud SE, Germer S, et al. Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach. Clin Chim Acta 2009;403:139-41.
30. Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999;97:527-38.
31. Greenberg RA, Chin L, Femino A, et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a (delta2/3) cancer-prone mouse. Cell 1999;97:515-25.
32. Weinstein B, Ciszek D. The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tis-sue- repair. Exp Gerontol 2002;37:615-27.
33. Noy A. Telomeres: the long and short of developing non-Hodgkin lymphoma. Clin Cancer Res 2009;15:7114-15.
34. Dolcetti R, De Rossi A. Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications. Med Res Rev 2012;32:233-53.
35. Damle RN, Batliwalla FM, Ghiotto F, et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood 2004;103:375-82.
36. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005;366:662-4.
37. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004;101:17312-5.
38. Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet oncol 2008;9:1048-57.
39. Epel ES. Psychological and metabolic stress: a recipe for accelerated cellular aging. Hormones (Athens) 2009;8:7-22.
40. Puterman E, Lin J, Blackburn E, et al. The power of exercise: buffering the effect of chronic stress on telomere length. PLoS One 2010;5:e10837.
41. Svenson U, Nordfjäll K, Baird D, et al. Blood cell telomere length is a dynamic feature. PloS one 2011;6:e21485.
42. Blackburn EH. Telomere states and cell fates. Nature 2000;408:53-6.